Literature DB >> 22717019

A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.

S P F Vos1, M J H Huibers, L Diels, A Arntz.   

Abstract

BACKGROUND: Interpersonal psychotherapy (IPT) seems to be as effective as cognitive behavioral therapy (CBT) in the treatment of major depression. Because the onset of panic attacks is often related to increased interpersonal life stress, IPT has the potential to also treat panic disorder. To date, a preliminary open trial yielded promising results but there have been no randomized controlled trials directly comparing CBT and IPT for panic disorder.
METHOD: This study aimed to directly compare the effects of CBT versus IPT for the treatment of panic disorder with agoraphobia. Ninety-one adult patients with a primary diagnosis of DSM-III or DSM-IV panic disorder with agoraphobia were randomized. Primary outcomes were panic attack frequency and an idiosyncratic behavioral test. Secondary outcomes were panic and agoraphobia severity, panic-related cognitions, interpersonal functioning and general psychopathology. Measures were taken at 0, 3 and 4 months (baseline, end of treatment and follow-up).
RESULTS: Intention-to-treat (ITT) analyses on the primary outcomes indicated superior effects for CBT in treating panic disorder with agoraphobia. Per-protocol analyses emphasized the differences between treatments and yielded larger effect sizes. Reductions in the secondary outcomes were equal for both treatments, except for agoraphobic complaints and behavior and the credibility ratings of negative interpretations of bodily sensations, all of which decreased more in CBT.
CONCLUSIONS: CBT is the preferred treatment for panic disorder with agoraphobia compared to IPT. Mechanisms of change should be investigated further, along with long-term outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22717019     DOI: 10.1017/S0033291712000876

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

Review 1.  Critical review of outcome research on interpersonal psychotherapy for anxiety disorders.

Authors:  John C Markowitz; Joshua Lipsitz; Barbara L Milrod
Journal:  Depress Anxiety       Date:  2014-02-03       Impact factor: 6.505

2.  Is Interpersonal Psychotherapy Infinitely Adaptable? A Compendium of the Multiple Modifications of IPT.

Authors:  Ellen Frank; Fiona C Ritchey; Jessica C Levenson
Journal:  Am J Psychother       Date:  2014

Review 3.  Advancing psychotherapy and evidence-based psychological interventions.

Authors:  Paul M G Emmelkamp; Daniel David; Tom Beckers; Peter Muris; Pim Cuijpers; Wolfgang Lutz; Gerhard Andersson; Ricardo Araya; Rosa M Banos Rivera; Michael Barkham; Matthias Berking; Thomas Berger; Christina Botella; Per Carlbring; Francesc Colom; Cecilia Essau; Dirk Hermans; Stefan G Hofmann; Susanne Knappe; Thomas H Ollendick; Filip Raes; Winfried Rief; Heleen Riper; Saskia Van Der Oord; Bram Vervliet
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

4.  Two Novel Cognitive Behavioral Therapy-Based Mobile Apps for Agoraphobia: Randomized Controlled Trial.

Authors:  Marina Christoforou; José Andrés Sáez Fonseca; Elias Tsakanikos
Journal:  J Med Internet Res       Date:  2017-11-24       Impact factor: 5.428

5.  Efficacy of a Transdiagnostic internet-based treatment for emotional disorders with a specific component to address positive affect: Study protocol for a randomized controlled trial.

Authors:  Amanda Díaz-García; Alberto González-Robles; Javier Fernández-Álvarez; Azucena García-Palacios; Rosa María Baños; Cristina Botella
Journal:  BMC Psychiatry       Date:  2017-04-20       Impact factor: 3.630

6.  On the Road to Personalized Psychotherapy: A Research Agenda Based on Cognitive Behavior Therapy for Depression.

Authors:  Marcus J H Huibers; Lorenzo Lorenzo-Luaces; Pim Cuijpers; Nikolaos Kazantzis
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.